glp 1 tirzepatide mounjaro FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Weight Loss Injections |
Description
If patients are able to get control over their weight now, its going to prevent so many problems for their health in the future
"Understanding your insurance coverage and out of pocket costs before you're treated should be table stakes in healthcare
Given that Mounjaro became the best-selling drug in Indian history, and has a better weight-loss profile than Sema (with similar side effects), Im confident the same dynamic will play out in the UK and US when semaglutide goes off patent in 2032
Insurance isnt accepted, and HSA/FSA eligibility isnt confirmed in available information
